Related Experiment Video
Updated: Mar 14, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Antidepressant Medication Prescribing Practices for Treatment of Major Depressive Disorder
Lara A Treviño1, Matthew W Ruble1, Kenneth Treviño1
1Dr. Lara Treviño and Dr. Gresky are with the Department of Clinical Analytics, Humana Inc., Irving, Texas (e-mail: l trevino@humana.com ). Dr. Ruble and Dr. Weinstein are with the Department of Medical Affairs, Humana Behavioral Health, Irving. Dr. Kenneth Treviño is in private practice in Dallas.
Objective:
The purpose of this study was to describe the prescribing practices of clinicians for patients with major depressive disorder (MDD).
Methods:
This population-based, descriptive study of insured patients (N=54,107) identified people who were 18 years or older, had a claim for MDD, had at least one prescription for an antidepressant medication in 2013, and had continuous insurance coverage during the study period. Prescription claims were evaluated to determine the most commonly prescribed antidepressant medication and most common dose.
Results:
The three most commonly prescribed antidepressant medications were citalopram (N=11,995, 22.2%), sertraline (N=10,791, 19.9%), and trazodone (N=9,501, 17.6%). The most common daily doses were 20 mg citalopram (N=6,304, 52.6%), 50 mg sertraline (N=4,173, 38.7%), and 100 mg trazodone (N=3,220, 33.9%).
Conclusions:
This is the first report of its kind that provides drug- and dosage-level details to demonstrate that antidepressant prescribing in clinical practice is largely within recommended guidelines.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drug Therapy
Antianxiety Medications
Depressive Disorders: MDD and Dysthymia
Depression: Overview

